BARINTHUS

Trademark usage description

pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceuticals for the treatment and/or prevention of cancer, infectious disea Read More

Classification Information

Class [005]
Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceuticals for the treatment and/or prevention of cancer, infectious diseases, and immune and autoimmune diseases; pharmaceutical preparations for the treatment and/or prevention of cancer, infectious diseases, and immune and autoimmune diseases; pharmaceutical products for the treatment and/or prevention of cancer, infectious diseases, and immune and autoimmune diseases; pharmaceuticals, pharmaceutical preparations and pharmaceutical products for the induction of immune tolerance; immunotherapeutics; immunotherapeutics for the treatment and/or prevention of cancer and infectious diseases, and immune and autoimmune diseases; vaccines; viral vaccines; vaccines for the treatment and/or prevention of influenza and other infectious diseases; vaccines for the treatment and/or prevention of cancer; viral antigens.

Classification kind code

Mark Details

Serial Number

2318245

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 256 on 28^th Jan 2025	Notification of Possible Opposition Sent
Submitted for opposition 257 on 28^th Mar 2024	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 27^th Mar 2024	Created
Submitted for opposition 31 on 27^th Mar 2024	Formalized
Submitted for opposition 30 on 8^th Jan 2024	Filed
Submitted for opposition 228 on 8^th Jan 2024	International Registration